Daniel F Marker
Affiliation: University of Rochester
- LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat proteinDaniel F Marker
Center for Neural Development and Disease, Department of Neurology, Child Neurology Division, University of Rochester, Rochester, NY, USA
J Neuroinflammation 9:261. 2012....
- The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disordersDaniel F Marker
Centers for Neural Development and Disease, University of Rochester, Rochester, New York 14642, USA
J Neurosci 33:9998-10010. 2013..In conclusion, these data provide compelling in vitro and in vivo evidence to investigate the utility of URMC-099 in other models of HAND with the goal of advancement to an adjunctive therapeutic agent...
- HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cellsShao Ming Lu
Center for Neural Development and Disease, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
PLoS ONE 6:e23915. 2011....